These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Strategic pooling of compounds for high-throughput screening. Hann M; Hudson B; Lewell X; Lifely R; Miller L; Ramsden N J Chem Inf Comput Sci; 1999; 39(5):897-902. PubMed ID: 10529988 [TBL] [Abstract][Full Text] [Related]
8. An efficient method for the detection and elimination of systematic error in high-throughput screening. Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024 [TBL] [Abstract][Full Text] [Related]
9. Microfluidic cell culture systems for drug research. Wu MH; Huang SB; Lee GB Lab Chip; 2010 Apr; 10(8):939-56. PubMed ID: 20358102 [TBL] [Abstract][Full Text] [Related]
10. Shifted Transversal Design smart-pooling for high coverage interactome mapping. Xin X; Rual JF; Hirozane-Kishikawa T; Hill DE; Vidal M; Boone C; Thierry-Mieg N Genome Res; 2009 Jul; 19(7):1262-9. PubMed ID: 19447967 [TBL] [Abstract][Full Text] [Related]
11. High-content, high-throughput screening for the identification of cytotoxic compounds based on cell morphology and cell proliferation markers. Martin HL; Adams M; Higgins J; Bond J; Morrison EE; Bell SM; Warriner S; Nelson A; Tomlinson DC PLoS One; 2014; 9(2):e88338. PubMed ID: 24505478 [TBL] [Abstract][Full Text] [Related]
12. Interpretation of uniform-well readouts. Josiah S Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data. Paricharak S; IJzerman AP; Bender A; Nigsch F ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899 [TBL] [Abstract][Full Text] [Related]
15. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data. Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559 [TBL] [Abstract][Full Text] [Related]
16. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates. White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568 [TBL] [Abstract][Full Text] [Related]
17. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds. Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544 [TBL] [Abstract][Full Text] [Related]
18. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. Mansour NR; Bickle QD PLoS Negl Trop Dis; 2010 Aug; 4(8):e795. PubMed ID: 20706580 [TBL] [Abstract][Full Text] [Related]
19. Design of small molecule libraries for NMR screening and other applications in drug discovery. Jacoby E; Davies J; Blommers MJ Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776 [TBL] [Abstract][Full Text] [Related]
20. Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay. Salzer E; Nixon E; Drewes G; Reinhard F; Bergamini G; Rau C J Lab Autom; 2016 Feb; 21(1):133-42. PubMed ID: 26169024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]